Mexico’s medicines regulator, COFEPRIS, says it is streamlining the registration of generic medicines and biosimilars by recognizing registration studies conducted in other countries. The move is part of Mexico’s shift towards greater regulatory reliance.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?